Durham drug developer BioCryst (Nasdaq: BCRX) has filed its first New Drug Application – for government-funded flu treatment peramivir. Rob Bennett, vice president of investor relations and operations, calls today a “history day” for the company. This time last year, today seemed unlikely.
Help employers find you! Check out all the jobs and post your resume.
